Abstract
Nitric oxide (NO) is a highly reactive gaseous free radical that regulates various physiological and pathological processes. Of these functions, the role of NO in the transformation, growth, and metastasis of cancers has generated particular interest. However, research describing the role of NO in cancers seems to be conflicting – some studies describe the suppressive role of NO in cancers, while numerous other studies describe the positive role of NO in tumor survival and progression. In this review, we shall examine the various roles of NO with a focus on how NO regulates tumor microenvironment and the various phases of tumor progression from neoplastic evolution, tumor growth, and metastasis. We will also discuss how NO-mediated S-nitrosylation, or covalent attachment of NO to protein cysteine thiols, regulates carcinogenesis by modulating proteins involved in the different phases of cancer development.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- NO::
-
nitric oxide
- NOS::
-
NO synthases
- SNO::
-
S-nitrosothiol
- RNOS::
-
reactive nitrogen–oxygen species
- Bcl-2::
-
B-cell lymphoma-2
- c-FLIP::
-
cellular FLICE-inhibitory protein
- DISC::
-
death-inducing signaling complex
- TNF-α::
-
tumor necrosis factor-α
- FasL::
-
Fas ligand
- JNK::
-
c-Jun N-terminal kinase
- MAPK::
-
mitogen-activated protein kinase
- ASK-1::
-
apoptosis signal-regulating kinase-1
- VEGF::
-
vascular endothelial growth factor
- HIF-1α::
-
hypoxia-inducible factor-1α
- VHL::
-
von Hippel–Lindau
- MMPs::
-
matrix metalloproteinases
References
Akhand, A.A., Pu, M., Senga, T., Kato, M., Suzuki, H., Miyata, T., Hamaguchi, M., and Nakashima, I. (1999). Nitric oxide controls src kinase activity through a sulfhydryl group modification-mediated Tyr-527-independent and Tyr-416-linked mechanism. J. Biol. Chem. 274, 25821–25826.
Ambs, S., Bennett, W.P., Merriam, W.G., Ogunfusika, M.O., Oser, S.M., Khan, M.A., Jones, R.T., and Harris, C.C. (1998a). Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53. Br. J. Cancer 78, 233–239.
Ambs, S., Ogunfusika, M.O., Merriam, W.G., Bennett, W.P., Billiar, T.R., and Harris, C.C. (1998b). Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice. Proc. Natl. Acad. Sci. U. S. A 95, 8823–8828.
Azad, N., Vallyathan, V., Wang, L., Tantishaiyakul, V., Stehlik, C., Leonard, S.S., and Rojanasakul, Y. (2006). S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteasomal degradation. A novel antiapoptotic mechanism that suppresses apoptosis. J. Biol. Chem. 281, 34124–34134.
Beckman, J.S., Ischiropoulos, H., Zhu, L., van der Woerd, M., Smith, C., Chen, J., Harrison, J., Martin, J.C., and Tsai, M. (1992). Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. Arch. Biochem. Biophys. 298, 438–445.
Beckman, J.S. and Koppenol, W.H. (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol 271, C1424–C1437.
Ben-Ezra, J.M., Kornstein, M.J., Grimes, M.M., and Krystal, G. (1994). Small cell carcinomas of the lung express the Bcl-2 protein. Am. J. Pathol. 145, 1036–1040.
Brennan, P.A., Downie, I.P., Langdon, J.D., and Zaki, G.A. (1999). Emerging role of nitric oxide in cancer. Br. J. Oral Maxillofac. Surg. 37, 370–373.
Broillet, M.C. (1999). S-nitrosylation of proteins. Cell Mol. Life Sci. 55, 1036–1042.
Callsen, D., Sandau, K.B., and Brune, B. (1999). Nitric oxide and superoxide inhibit platelet-derived growth factor receptor phosphotyrosine phosphatases. Free Radic. Biol. Med. 26, 1544–1553.
Carmeliet, P. and Jain, R.K. (2000). Angiogenesis in cancer and other diseases. Nature 407, 249–257.
Carver, D.J., Gaston, B., Deronde, K., and Palmer, L.A. (2007). Akt-mediated activation of HIF-1 in pulmonary vascular endothelial cells by S-nitrosoglutathione. Am. J. Respir. Cell Mol. Biol. 37, 255–263.
Caselli, A., Chiarugi, P., Camici, G., Manao, G., and Ramponi, G. (1995). In vivo inactivation of phosphotyrosine protein phosphatases by nitric oxide. FEBS Lett. 374, 249–252.
Chanvorachote, P., Nimmannit, U., Stehlik, C., Wang, L., Jiang, B.H., Ongpipatanakul, B., and Rojanasakul, Y. (2006). Nitric oxide regulates cell sensitivity to cisplatin-induced apoptosis through S-nitrosylation and inhibition of Bcl-2 ubiquitination. Cancer Res. 66, 6353–6360.
Chanvorachote, P., Nimmannit, U., Wang, L., Stehlik, C., Lu, B., Azad, N., and Rojanasakul, Y. (2005). Nitric oxide negatively regulates Fas CD95-induced apoptosis through inhibition of ubiquitin-proteasome-mediated degradation of FLICE inhibitory protein. J. Biol. Chem. 280, 42044–42050.
Chiarugi, V., Magnelli, L., and Gallo, O. (1998). Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (review). Int. J. Mol. Med. 2, 715–719.
Cobbs, C.S., Brenman, J.E., Aldape, K.D., Bredt, D.S., and Israel, M.A. (1995). Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 55, 727–730.
Davel, L., D’Agostino, A., Espanol, A., Jasnis, M.A., Lauria de, C.L., de Lustig, E.S., and Sales, M.E. (2002). Nitric oxide synthase-cyclooxygenase interactions are involved in tumor cell angiogenesis and migration. J. Biol. Regul. Homeost. Agents 16, 181–189.
Dehm, S.M. and Bonham, K. (2004). SRC gene expression in human cancer: the role of transcriptional activation. Biochem. Cell Biol. 82, 263–274.
Deininger, M.H., Wybranietz, W.A., Graepler, F.T., Lauer, U.M., Meyermann, R., and Schluesener, H.J. (2003). Endothelial endostatin release is induced by general cell stress and modulated by the nitric oxide/cGMP pathway. FASEB J. 17, 1267–1276.
delaTorre, A., Schroeder, R.A., Bartlett, S.T., and Kuo, P.C. (1998). Differential effects of nitric oxide-mediated S-nitrosylation on p50 and c-jun DNA binding. Surgery 124, 137–141; discussion 141–132.
Dhakshinamoorthy, S. and Porter, A.G. (2004). Nitric oxide-induced transcriptional up-regulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells. J. Biol. Chem. 279, 20096–20107.
Doi, K., Akaike, T., Horie, H., Noguchi, Y., Fujii, S., Beppu, T., Ogawa, M., and Maeda, H. (1996). Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer 77, 1598–1604.
Dong, Z., Staroselsky, A.H., Qi, X., Xie, K., and Fidler, I.J. (1994). Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res. 54, 789–793.
Ekmekcioglu, S., Ellerhorst, J.A., Prieto, V.G., Johnson, M.M., Broemeling, L.D., and Grimm, E.A. (2006). Tumor iNOS predicts poor survival for stage III melanoma patients. Int. J. Cancer 119, 861–866.
Foster, M.W., McMahon, T.J., and Stamler, J.S. (2003). S-nitrosylation in health and disease. Trends Mol. Med. 9, 160–168.
Fukumura, D., Kashiwagi, S., and Jain, R.K. (2006). The role of nitric oxide in tumour progression. Nat. Rev. Cancer 6, 521–534.
Gansauge, S., Nussler, A.K., Beger, H.G., and Gansauge, F. (1998). Nitric oxide-induced apoptosis in human pancreatic carcinoma cell lines is associated with a G1-arrest and an increase of the cyclin-dependent kinase inhibitor p21WAF1/CIP1. Cell Growth Differ. 9, 611–617.
Garban, H.J., Marquez-Garban, D.C., Pietras, R.J., and Ignarro, L.J. (2005). Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: regulation of estrogen-dependent gene transcription. Proc. Natl. Acad. Sci. USA 102, 2632–2636.
Gaston, B.M., Carver, J., Doctor, A., and Palmer, L.A. (2003). S-nitrosylation signaling in cell biology. Mol. Interv. 3, 253–263.
Gow, A.J., Chen, Q., Hess, D.T., Day, B.J., Ischiropoulos, H., and Stamler, J.S. (2002). Basal and stimulated protein S-nitrosylation in multiple cell types and tissues. J. Biol. Chem. 277, 9637–9640.
Green, D.R. and Reed, J.C. (1998). Mitochondria and apoptosis. Science 281, 1309–1312.
Haendeler, J., Weiland, U., Zeiher, A.M., and Dimmeler, S. (1997). Effects of redox-related congeners of NO on apoptosis and caspase-3 activity. Nitric Oxide 1, 282–293.
Haendeler, J., Hoffmann, J., Tischler, V., Berk, B.C., Zeiher, A.M., and Dimmeler, S. (2002). Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat. Cell Biol. 4, 743–749.
Hajri, A., Metzger, E., Vallat, F., Coffy, S., Flatter, E., Evrard, S., Marescaux, J., and Aprahamian, M. (1998). Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies. Br. J. Cancer 78, 841–849.
Harris, L.K., McCormick, J., Cartwright, J.E., Whitley, G.S., and Dash, P.R. (2008). S-nitrosylation of proteins at the leading edge of migrating trophoblasts by inducible nitric oxide synthase promotes trophoblast invasion. Exp. Cell Res. 314, 1765–1776.
Hess, D.T., Matsumoto, A., Kim, S.O., Marshall, H.E., and Stamler, J.S. (2005). Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell Biol. 6, 150–166.
Hirst, D. and Robson, T. (2007). Targeting nitric oxide for cancer therapy. J. Pharm. Pharmacol. 59, 3–13.
Hoffmann, J., Haendeler, J., Zeiher, A.M., and Dimmeler, S. (2001). TNFalpha and oxLDL reduce protein S-nitrosylation in endothelial cells. J. Biol. Chem. 276, 41383–41387.
Ichijo, H., Nishida, E., Irie, K., Ten, D.P., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K., and Gotoh, Y. (1997). Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90–94.
Ignarro, L.J. (1989). Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ. Res. 65, 1–21.
Ignarro, L.J., Buga, G.M., Wood, K.S., Byrns, R.E., and Chaudhuri, G. (1987). Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U. S. A 84, 9265–9269.
Ikegaki, N., Katsumata, M., Minna, J., and Tsujimoto, Y. (1994). Expression of bcl-2 in small cell lung carcinoma cells. Cancer Res. 54, 6–8.
Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.L., Schroter, M., Burns, K., Mattmann, C., Rimoldi, D., French, L.E., and Tschopp, J. (1997). Inhibition of death receptor signals by cellular FLIP. Nature 388, 190–195.
Ishii, Y., Ogura, T., Tatemichi, M., Fujisawa, H., Otsuka, F., and Esumi, H. (2003). Induction of matrix metalloproteinase gene transcription by nitric oxide and mechanisms of MMP-1 gene induction in human melanoma cell lines. Int. J. Cancer 103, 161–168.
Ishima, Y., Akaike, T., Kragh-Hansen, U., Hiroyama, S., Sawa, T., Suenaga, A., Maruyama, T., Kai, T., and Otagiri, M. (2008). S-Nitrosylated human serum albumin-mediated cytoprotective activity is enhanced by fatty acid binding. J. Biol. Chem. 283, 34966–34975.
Iyer, A.K., Azad, N., Wang, L., and Rojanasakul, Y. (2008). Role of S-nitrosylation in apoptosis resistance and carcinogenesis. Nitric. Oxide. 19, 146–151.
Jadeski, L.C., Chakraborty, C., and Lala, P.K. (2003). Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase. Int. J. Cancer 106, 496–504.
Jadeski, L.C., Hum, K.O., Chakraborty, C., and Lala, P.K. (2000). Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int. J. Cancer 86, 30–39.
Jenkins, D.C., Charles, I.G., Thomsen, L.L., Moss, D.W., Holmes, L.S., Baylis, S.A., Rhodes, P., Westmore, K., Emson, P.C., and Moncada, S. (1995). Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA 92, 4392–4396.
Jiang, S.X., Sato, Y., Kuwao, S., and Kameya, T. (1995). Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas. J. Pathol. 177, 135–138.
Kang-Decker, N., Cao, S., Chatterjee, S., Yao, J., Egan, L.J., Semela, D., Mukhopadhyay, D., and Shah, V. (2007). Nitric oxide promotes endothelial cell survival signaling through S-nitrosylation and activation of dynamin-2. J. Cell Sci. 120, 492–501.
Kashiwagi, S., Izumi, Y., Gohongi, T., Demou, Z.N., Xu, L., Huang, P.L., Buerk, D.G., Munn, L.L., Jain, R.K., and Fukumura, D. (2005). NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels. J. Clin. Invest 115, 1816–1827.
Kelleher, Z.T., Matsumoto, A., Stamler, J.S., and Marshall, H.E. (2007). NOS2 regulation of NF-kappaB by S-nitrosylation of p65. J. Biol. Chem. 282, 30667–30672.
Kim, J.E. and Tannenbaum, S.R. (2004). S-Nitrosation regulates the activation of endogenous procaspase-9 in HT-29 human colon carcinoma cells. J. Biol. Chem. 279, 9758–9764.
Kim, Y.M., Kim, T.H., Chung, H.T., Talanian, R.V., Yin, X.M., and Billiar, T.R. (2000). Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8. Hepatology 32, 770–778.
Kimura, H., Weisz, A., Kurashima, Y., Hashimoto, K., Ogura, T., D, Acquisto, F., Addeo, R., Makuuchi, M., and Esumi, H. (2000). Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95, 189–197.
Kimura, H., Weisz, A., Ogura, T., Hitomi, Y., Kurashima, Y., Hashimoto, K., D,Acquisto, F., Makuuchi, M., and Esumi, H. (2001). Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J. Biol. Chem. 276, 2292–2298.
Klas, C., Debatin, K.M., Jonker, R.R., and Krammer, P.H. (1993). Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5, 625–630.
Klotz, T., Bloch, W., Volberg, C., Engelmann, U., and Addicks, K. (1998). Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer 82, 1897–1903.
Knowles, R.G. (1996). Nitric oxide synthases. Biochem. Soc. Trans. 24, 875–878.
Knowles, R.G. and Moncada, S. (1994). Nitric oxide synthases in mammals. Biochem. J. 298 (Pt 2), 249–258.
Kwak, J.Y., Han, M.K., Choi, K.S., Park, I.H., Park, S.Y., Sohn, M.H., Kim, U.H., McGregor, J.R., Samlowski, W.E., and Yim, C.Y. (2000). Cytokines secreted by lymphokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells. Cell Immunol. 203, 84–94.
Lala, P.K. and Chakraborty, C. (2001). Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 2, 149–156.
Lala, P.K. and Orucevic, A. (1998). Role of nitric oxide in tumor progression: lessons from experimental tumors. Cancer Metastasis Rev. 17, 91–106.
Lancaster, J.R., Jr. and Xie, K. (2006). Tumors face NO problems? Cancer Res. 66, 6459–6462.
Lander, H.M., Ogiste, J.S., Pearce, S.F., Levi, R., and Novogrodsky, A. (1995). Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J. Biol. Chem. 270, 7017–7020.
Lane, P., Hao, G., and Gross, S.S. (2001). S-nitrosylation is emerging as a specific and fundamental posttranslational protein modification: head-to-head comparison with O-phosphorylation. Sci. STKE. 2001, RE1.
Lechner, M., Lirk, P., and Rieder, J. (2005). Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Semin. Cancer Biol. 15, 277–289.
Li, C.Q., Robles, A.I., Hanigan, C.L., Hofseth, L.J., Trudel, L.J., Harris, C.C., and Wogan, G.N. (2004). Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res. 64, 3022–3029.
Li, F., Sonveaux, P., Rabbani, Z.N., Liu, S., Yan, B., Huang, Q., Vujaskovic, Z., Dewhirst, M.W., and Li, C.Y. (2007). Regulation of HIF-1alpha stability through S-nitrosylation. Mol. Cell 26, 63–74.
Li, S. and Whorton, A.R. (2003). Regulation of protein tyrosine phosphatase 1B in intact cells by S-nitrosothiols. Arch. Biochem. Biophys. 410, 269–279.
Lirk, P., Hoffmann, G., and Rieder, J. (2002). Inducible nitric oxide synthase – time for reappraisal. Curr. Drug Targets. Inflamm. Allergy 1, 89–108.
Mannick, J.B., Schonhoff, C., Papeta, N., Ghafourifar, P., Szibor, M., Fang, K., and Gaston, B. (2001). S-Nitrosylation of mitochondrial caspases. J. Cell Biol. 154, 1111–1116.
Mannick, J.B., Hausladen, A., Liu, L., Hess, D.T., Zeng, M., Miao, Q.X., Kane, L.S., Gow, A.J., and Stamler, J.S. (1999). Fas-induced caspase denitrosylation. Science 284, 651–654.
Matsumoto, A., Comatas, K.E., Liu, L., and Stamler, J.S. (2003). Screening for nitric oxide-dependent protein-protein interactions. Science 301, 657–661.
Metzen, E., Zhou, J., Jelkmann, W., Fandrey, J., and Brune, B. (2003). Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Mol. Biol. Cell 14, 3470–3481.
Mikkelsen, R.B. and Wardman, P. (2003). Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 22, 5734–5754.
Mocellin, S., Bronte, V., and Nitti, D. (2007). Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Med. Res. Rev. 27, 317–352.
Moncada, S. (1993). The L-arginine: nitric oxide pathway, cellular transduction and immunological roles. Adv. Second Messenger Phosphoprotein Res. 28, 97–99.
Montrucchio, G., Lupia, E., de, M.A., Battaglia, E., Arese, M., Tizzani, A., Bussolino, F., and Camussi, G. (1997). Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha. Am. J. Pathol. 151, 557–563.
Morita, E.H., Ohkubo, T., Kuraoka, I., Shirakawa, M., Tanaka, K., and Morikawa, K. (1996). Implications of the zinc-finger motif found in the DNA-binding domain of the human XPA protein. Genes Cells 1, 437–442.
Mortensen, K., Skouv, J., Hougaard, D.M., and Larsson, L.I. (1999). Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53. J. Biol. Chem. 274, 37679–37684.
Nagata, S. (1997). Apoptosis by death factor. Cell 88, 355–365.
Nakano, S., Matsukado, K., and Black, K.L. (1996). Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Res. 56, 4027–4031.
Nathan, C. and Xie, Q.W. (1994). Nitric oxide synthases: roles, tolls, and controls. Cell 78, 915–918.
Nathan, C.F. and Hibbs, J.B., Jr. (1991). Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3, 65–70.
Nikitovic, D., Holmgren, A., and Spyrou, G. (1998). Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and Fos. Biochem. Biophys. Res. Commun. 242, 109–112.
Oltvai, Z.N., Milliman, C.L., and Korsmeyer, S.J. (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609–619.
Padmaja, S. and Huie, R.E. (1993). The reaction of nitric oxide with organic peroxyl radicals. Biochem. Biophys. Res. Commun. 195, 539–544.
Palmer, R.M., Ferrige, A.G., and Moncada, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524–526.
Park, H.S., Huh, S.H., Kim, M.S., Lee, S.H., and Choi, E.J. (2000). Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein kinase by means of S-nitrosylation. Proc. Natl. Acad. Sci. U. S. A 97, 14382–14387.
Park, H.S., Yu, J.W., Cho, J.H., Kim, M.S., Huh, S.H., Ryoo, K., and Choi, E.J. (2004). Inhibition of apoptosis signal-regulating kinase 1 by nitric oxide through a thiol redox mechanism. J. Biol. Chem. 279, 7584–7590.
Park, S.W., Lee, S.G., Song, S.H., Heo, D.S., Park, B.J., Lee, D.W., Kim, K.H., and Sung, M.W. (2003). The effect of nitric oxide on cyclooxygenase-2 (COX-2) overexpression in head and neck cancer cell lines. Int. J. Cancer 107, 729–738.
Pugh, C.W. and Ratcliffe, P.J. (2003). Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9, 677–684.
Radomski, M.W., Jenkins, D.C., Holmes, L., and Moncada, S. (1991). Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res. 51, 6073–6078.
Raspollini, M.R., Amunni, G., Villanucci, A., Boddi, V., Baroni, G., Taddei, A., and Taddei, G.L. (2004). Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome. Gynecol. Oncol. 92, 806–812.
Ravi, K., Brennan, L.A., Levic, S., Ross, P.A., and Black, S.M. (2004). S-nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity. Proc. Natl. Acad. Sci. USA 101, 2619–2624.
Reed, J.C. (1997). Cytochrome c: can,t live with it – can,t live without it. Cell 91, 559–562.
Ridnour, L.A., Thomas, D.D., Donzelli, S., Espey, M.G., Roberts, D.D., Wink, D.A., and Isenberg, J.S. (2006). The biphasic nature of nitric oxide responses in tumor biology. Antioxid. Redox. Signal. 8, 1329–1337.
Rizzo, M.A., and Piston, D.W. (2003). Regulation of beta cell glucokinase by S-nitrosylation and association with nitric oxide synthase. J. Cell Biol. 161, 243–248.
Rosbe, K.W., Prazma, J., Petrusz, P., Mims, W., Ball, S.S., and Weissler, M.C. (1995). Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngol. Head Neck Surg. 113, 541–549.
Salvesen, G.S. and Dixit, V.M. (1997). Caspases: intracellular signaling by proteolysis. Cell 91, 443–446.
Sidorkina, O., Espey, M.G., Miranda, K.M., Wink, D.A., and Laval, J. (2003). Inhibition of poly(ADP-RIBOSE) polymerase (PARP) by nitric oxide and reactive nitrogen oxide species. Free Radic. Biol. Med. 35, 1431–1438.
Siegert, A., Rosenberg, C., Schmitt, W.D., Denkert, C., and Hauptmann, S. (2002). Nitric oxide of human colorectal adenocarcinoma cell lines promotes tumour cell invasion. Br. J. Cancer 86, 1310–1315.
Snyder, S.H. and Bredt, D.S. (1992). Biological roles of nitric oxide. Sci. Am. 266, 68–7.
Stamler, J.S. (1994). Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78, 931–936.
Stamler, J.S., Lamas, S., and Fang, F.C. (2001). Nitrosylation. the prototypic redox-based signaling mechanism. Cell 106, 675–683.
Stamler, J.S., Simon, D.I., Osborne, J.A., Mullins, M.E., Jaraki, O., Michel, T., Singel, D.J., and Loscalzo, J. (1992). S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. U. S. A 89, 444–448.
Stamler, J.S., Toone, E.J., Lipton, S.A., and Sucher, N.J. (1997). (S)NO signals: translocation, regulation, and a consensus motif. Neuron 18, 691–696.
Sumbayev, V.V., Budde, A., Zhou, J., and Brune, B. (2003). HIF-1 alpha protein as a target for S-nitrosation. FEBS Lett. 535, 106–112.
Thomsen, L.L., Lawton, F.G., Knowles, R.G., Beesley, J.E., Riveros-Moreno, V., and Moncada, S. (1994). Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 54, 1352–1354.
Thomsen, L.L., Miles, D.W., Happerfield, L., Bobrow, L.G., Knowles, R.G., and Moncada, S. (1995). Nitric oxide synthase activity in human breast cancer. Br. J. Cancer 72, 41–44.
Torok, N.J., Higuchi, H., Bronk, S., and Gores, G.J. (2002). Nitric oxide inhibits apoptosis downstream of cytochrome C release by nitrosylating caspase 9. Cancer Res. 62, 1648–1653.
Wallach, D., Varfolomeev, E.E., Malinin, N.L., Goltsev, Y.V., Kovalenko, A.V., and Boldin, M.P. (1999). Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17, 331–367.
Wang, G.Y., Ji, B., Wang, X., and Gu, J.H. (2005). Anti-cancer effect of iNOS inhibitor and its correlation with angiogenesis in gastric cancer. World J. Gastroenterol. 11, 3830–3833.
Whalen, E.J., Foster, M.W., Matsumoto, A., Ozawa, K., Violin, J.D., Que, L.G., Nelson, C.D., Benhar, M., Keys, J.R., Rockman, H.A., Koch, W.J., Daaka, Y., Lefkowitz, R.J., and Stamler, J.S. (2007). Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell 129, 511–522.
Williams, E.L. and Djamgoz, M.B. (2005). Nitric oxide and metastatic cell behaviour. Bioessays 27, 1228–1238.
Williams, J.G., Pappu, K., and Campbell, S.L. (2003). Structural and biochemical studies of p21Ras S-nitrosylation and nitric oxide-mediated guanine nucleotide exchange. Proc. Natl. Acad. Sci. U. S. A 100, 6376–6381.
Wink, D.A., Vodovotz, Y., Laval, J., Laval, F., Dewhirst, M.W., and Mitchell, J.B. (1998). The multifaceted roles of nitric oxide in cancer. Carcinogenesis 19, 711–721.
Wyllie, A.H., Kerr, J.F., and Currie, A.R. (1980). Cell death: the significance of apoptosis. Int. Rev. Cytol. 68, 251–306.
Xie, K., Huang, S., Dong, Z., Gutman, M., and Fidler, I.J. (1995a). Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. Cancer Res. 55, 3123–3131.
Xie, K., Huang, S., Dong, Z., Juang, S.H., Gutman, M., Xie, Q.W., Nathan, C., and Fidler, I.J. (1995b). Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med. 181, 1333–1343.
Yang, J., Liu, X., Bhalla, K., Kim, C.N., Ibrado, A.M., Cai, J., Peng, T.I., Jones, D.P., and Wang, X. (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129–1132.
Yasinska, I.M. and Sumbayev, V.V. (2003). S-nitrosation of Cys-800 of HIF-1alpha protein activates its interaction with p300 and stimulates its transcriptional activity. FEBS Lett. 549, 105–109.
Yuan, J. (1997). Transducing signals of life and death. Curr. Opin. Cell Biol. 9, 247–251.
Acknowledgment
This work was supported by the National Institutes of Health Grant R01-HL076340.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Iyer, A.K.V., Azad, N., Wang, L., Rojanasakul, Y. (2010). S-Nitrosylation – How Cancer Cells Say NO to Cell Death. In: Bonavida, B. (eds) Nitric Oxide (NO) and Cancer. Cancer Drug Discovery and Development. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1432-3_5
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1432-3_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1431-6
Online ISBN: 978-1-4419-1432-3
eBook Packages: MedicineMedicine (R0)